Maravai Lifesciences Holdings MRVI
NASDAQ MRVI
$7.32 -0.05 (-0.68%)
At close: Sep 4, 2026 · 4:00 PM EDT

Maravai Lifesciences Holdings (MRVI) Other Non Operating Income (2020 - 2026)

Maravai Lifesciences Holdings (MRVI) posted quarterly Other Non Operating Income of -$494000.0 for Q1 2026, down 2158.33% year-over-year from $24000.0 in Q1 2025, and down 1048.84% quarter-over-quarter from -$43000.0 in Q4 2025.

Analysis

Maravai Lifesciences Holdings (MRVI) Other Non Operating Income (2020 - 2026) Analysis & Trends

Maravai Lifesciences Holdings' Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$494000.0 for Q1 2026.

  • In Q1 2026, Other Non Operating Income fell 2158.33% year-over-year to -$494000.0; the TTM figure through Mar 2026 stood at -$4.7 million (down 42.86% YoY), while the FY2025 annual figure was -$4.2 million, down 30.28% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at -$494000.0, down from -$43000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $1.4 million in Q4 2023, with the low at -$4.1 million in Q2 2025.
  • The 5-year median for Other Non Operating Income is -$43000.0 (2025), against an average of -$464600.0.
  • Peak annual rise in Other Non Operating Income reached 429.35% in 2022, while the deepest fall reached 6766.67% in 2022.
  • Maravai Lifesciences Holdings' Other Non Operating Income stood at $1.1 million in 2022, then jumped by 30.26% to $1.4 million in 2023, then sank by 157.94% to -$803000.0 in 2024, then soared by 94.65% to -$43000.0 in 2025, then tumbled by 1048.84% to -$494000.0 in 2026.
  • Business Quant data shows MRVI's Other Non Operating Income at -$494000.0 in Q1 2026, -$43000.0 in Q4 2025, and -$71000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Maravai Lifesciences Holdings 1.09 Bn 1.02 Bn 20.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.01 Mn
Mar 31, 2026 -494,000.00
Dec 31, 2025 -43,000.00
Sep 30, 2025 -71,000.00
Jun 30, 2025 -4.06 Mn
Mar 31, 2025 24,000.00
Dec 31, 2024 -803,000.00
Sep 30, 2024 72,000.00
Jun 30, 2024 -2.56 Mn
Mar 31, 2024 106,000.00
Dec 31, 2023 49,000.00
Sep 30, 2023 66,000.00
Jun 30, 2023 -1.62 Mn
Mar 31, 2023 168,000.00
Dec 31, 2022 914,000.00
Sep 30, 2022 -4,000.00
Jun 30, 2022 -1.28 Mn
Mar 31, 2022 -208,000.00
Dec 31, 2021 201,000.00
Sep 30, 2021 78,000.00